ICICI Prudential NASDAQ 100 Index Fund - Direct Plan - Growth vs ICICI Prudential Nifty Pharma Index Fund - Direct Plan - Growth
A side-by-side comparison of returns, cost, size and risk. Both funds sit in the same category, so these figures are directly comparable.
NAV as of 9 Nov 2026. Returns over 1 year are annualised. Past performance does not indicate future returns, and this comparison is not a recommendation.
| Metric | ICICI Prudential NASDAQ 100 Index Fund | ICICI Prudential Nifty Pharma Index Fund |
|---|---|---|
| Category | Index Funds | Index Funds |
| Fund house | ICICI Prudential Mutual Fund | ICICI Prudential Mutual Fund |
| NAV | ₹22.7632 | ₹22.3644 |
| 1Y return | +24.39% | +12.79% |
| 3Y return | +31.29% | +19.39% |
| 5Y return | +18.75% | — |
| AUM | ₹3,738 Cr | ₹163 Cr |
| Expense ratio | 0.63% | 0.51% |
| Risk | Very High | Very High |
Highlighting marks the higher return or lower cost on rows where both funds have data. It is arithmetic, not advice — a cheaper or higher-returning fund is not automatically the better choice for you.